SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- Orexigen
Therapeutics, Inc. (Nasdaq: OREX) announced today that management
will present at the 2017 BIO Investor Forum on Tuesday, October 17th, at 9:15 AM PDT (12:15 PM
EDT).
Investors, analysts, and the general public are invited to
listen to the presentation via webcast, which can be accessed on
the "Investors" section of the Orexigen web site at
www.orexigen.com. The webcast will be archived and available for
replay for 14 days following the call.
Orexigen Investor Contact:
Jason Keyes, Chief Financial
Officer
+1-858- 875-8600
ir@orexigen.com
Orexigen Media Contact:
Erika Hackmann
Y&R
+1-917-538-3375
erika.hackmann@yr.com
View original
content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-at-the-2017-bio-investor-forum-300536244.html
SOURCE Orexigen Therapeutics, Inc.